Healthcare workers gathered around a smartphone during a HerLens session

Helping Frontline Care Screen More Accurately With Smartphones

HerLens provides a real-time AI second opinion for more accurate cervical screening.

Partner with us

A leading social enterprise backed by

  • US-ASEAN STIC
  • Swiss Innovation Challenge Asia
  • 22Health Ventures
  • YSEALI Seeds for the Future
  • Lift Women
  • NUS Digital Advanced Technology Accelerator, Yong Loo Lin School of Medicine
  • IMERI FKUI

  • Apple Developer
    Academy

  • Pikiran Terbaik Negeri
  • Hult Prize

The Gap We Couldn't Ignore

Too Many Women Are Diagnosed Late

Indonesia's most accessible cervical cancer screening method, the Visual Inspection with Acetic Acid (VIA) test, relies on frontline health workers' subjective visual interpretation, which can lead to misinterpretation and delayed care.

Indonesian women lost to cervical cancer every year
20,700
Accuracy of the naked-eye VIA exam
66%
Cases missed at the point of screening
1 in 3
Target women ever screened at all
<1 in 10
Three women reviewing a cervical screening form together

HerLens closes this gap where it begins: at the point of screening.

Built around existing VIA workflow, HerLens brings AI-powered cervical screening to a smartphone with user-friendly experience.

So healthcare workers screen more accurately and women can receive earlier diagnoses.

Designed for Frontline Care

Higher Accuracy, Smarter Workflow

HerLens fits into the existing VIA exam, helping health workers screen more accurately with real-time AI support.

Capture with Clarity

During the VIA exam, healthcare workers capture cervical images before and after acetic acid application.

  • Guided image capture for precise images
  • High-quality camera imaging
  • Green filter to detect precancerous lesion visibility
Learn more about Capture with Clarity
HerLens camera screen guiding the health worker to center the cervix before taking the photo

AI-Assisted Assessment

On-device AI analyzes cervical images in real time, providing screening results to support healthcare workers’ decisions.

  • 87.5% specificity vs. 66% with naked-eye interpretation alone
  • Instant VIA Positive or VIA Negative interpretation
  • Confidence score for every AI interpretation
Learn more about AI-Assisted Assessment
HerLens result screen showing a VIA Positive interpretation with a 97% confidence level

Document Every Examination

Automatically store examination records, allowing healthcare workers to review cases and support continuous care anytime.

  • Patient information and reproductive health history
  • Digital consent form for every examination
  • Secure examination records stored in-app
Learn more about Document Every Examination
HerLens home screen summarizing screened, VIA positive, and VIA negative examinations

Share Results Securely

Make examination results accessible while keeping patient information protected.

  • Accessible result sharing through secure links
  • Verified access to protect patient data
  • Real-time updates when records change
Learn more about Share Results Securely
Examination results email with a button to open the results securely

One Care Ecosystem

For Every Step of Care, Connecting All Network

HerLens supports the full cervical care journey, from education and screening to detection, bringing healthcare workers, clinics, and organizations together through HerLens.

Fostering Awareness and Training Through the BrightHer Community

Since 2025, we've built BrightHer to reach cervical cancer communities across Indonesia, empowering healthcare workers and raising cervical cancer awareness among everyone.

BrightHer
  • 6,916people engaged
  • 408women screened
  • 235modules distributed
  • 76doctors & midwives trained
  • 5provinces covered

12 Locations and Keep Growing

Voices from The Field

The World Believes in HerLens

  • OB-GYN Specialist

    HerLens is a collective force to support screening with VIA method, in line with WHO's goal to eradicate cervical cancer.

    Dr. dr. Gatot Purwoto, Sp.OG, Subsp.Onk, MPH

    Obstetrics and Gynecology Specialist, Dr. Cipto Mangunkusumo Hospital

  • Government

    The cancer screening technology has advanced. HerLens aims to achieve an accuracy rate of 90%.

    Budi Arie Setiadi

    Ex-Minister of Communication and Informatics Indonesia

  • Academic Representative

    This shows a commitment to developing practical tech solutions that improve the quality of life for Indonesians.

    Ahmad Gamal, S.Ars., M.Si., M.U.P., Ph.D.

    Vice Rector, University of Indonesia

For Those Who Care About Women's Health

Every woman deserves a chance at early detection

Partner with HerLens to bring earlier, more reliable cervical screening to every woman.

Partner with us
Health workers gathered around smartphones, trying HerLens on training models